Details for 2016816810

Up to date per 03.04.2026

Actions

Title / Product Name

ENASIDENIB ZUR BEHANDLUNG VON REZIVIDIERER ODER REFRÄKTARER AKUTER MYELOISCHER LEUKÄMIE

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2016816810

EP Publication Number

3419593

E-Number

1476971

Language

PCT Number

US16064615

Publication Date

02.01.2019 A

23.03.2022 B1

Registration Date

23.03.2022

AT Publication Date

15.04.2022

Application Date

02.12.2016

Registration Number

Priorities

26.02.2016

201662300673 P

IPC

A61K 31/365 20060101AFI20210708BHEP

Maximum Duration of Protection

02.12.2036

Owner

Celgene Corporation86 Morris Avenue Summit, NJ 07901US

Les Laboratoires Servier50 rue Carnot 92284 Suresnes CedexFR

Representative

No representatives present

Inventor

AMATANGELO, Michael53 Canterbury Rd. Madison, NJ 07940US

HU, Xiaolan31 Charleston Drive Skillman, NJ 08558US

THAKURTA, Anjan30 Benedict Crescent Basking Ridge, NJ 07920US

CHOE, Sung Eun12 Kimball Road Lexington, MA 02421US

WU, Bin32 Albert Avenue Belmont, MA 02478US